You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma,%20Renal%20Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Delving Into Participation Trends in Renal Cell Carcinoma

Not yet recruiting
  • Renal Cell Carcinoma
    • San Francisco, California
      Power Life Sciences
    Oct 16, 2023

    Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

    Completed
    • Carcinoma, Renal Cell
    • We do not have any interventions. This study is based on obseravation.
    • (no location specified)
    Oct 27, 2023

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

    Recruiting
    • Renal Cell Carcinoma
    • 68Ga-NY104 PET/CT
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 5, 2023

    Renal Cell Carcinoma Trial (HS-10516)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 24, 2023

    Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

    Available
    • Clear Cell Renal Cell Carcinoma
    • 89Zr-DFO-girentuximab
    • Los Angeles, California
      UCLA
    Oct 12, 2023

    Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pembrolizumab injection
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 20, 2023

    Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • ST-1898 tablets
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Nov 6, 2023

    Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

    Recruiting
    • Carcinoma, Renal Cell
    • Kidney Neoplasms
      • Yiwu, Zhejiang, China
        The Fourth Affiliated Hospital Zhejiang University School of Med
      Mar 27, 2023

      Carcinoma, Renal Cell Trial (Orellanine)

      Not yet recruiting
      • Carcinoma, Renal Cell
      • (no location specified)
      Jan 25, 2023

      Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

      Not yet recruiting
      • Papillary Renal Cell Carcinoma
      • (no location specified)
      Nov 24, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 28, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Cytoreductive Nephrectomy
      • (no location specified)
      Jul 3, 2023

      Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

      Recruiting
      • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
      • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
      • Shanghai, Shanghai, China
        Shanghai Renji Hospital
      Sep 12, 2023

      Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pucotenlimab Combined With Lenvatinib
      • Guangzhou, Other (Non U.s.), China
        Sun Yat-sen University Cancer Center
      Nov 10, 2023

      Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • +3 more
      • Chengdu, Sichuan, China
        West China Hospital
      Apr 10, 2023

      Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

      Not yet recruiting
      • Renal Cell Carcinoma
      • +2 more
      • Implantable Microdevice (IMD)
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 17, 2023

      Carcinoma, Renal Cell Trial in Madison (Stereotactic Body Radiation Therapy (SBRT), Microwave Ablation (MWA))

      Active, not recruiting
      • Carcinoma, Renal Cell
      • Stereotactic Body Radiation Therapy (SBRT)
      • Microwave Ablation (MWA)
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Jan 9, 2023

      Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • (no location specified)
      May 14, 2023

      go Back Into Records and Observe How People With Metastatic

      Not yet recruiting
      • Carcinoma, Renal Cell
      • Clear-cell Metastatic Renal Cell Carcinoma
      • Istanbul, Turkey
        Pfizer
      Feb 15, 2023

      Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)

      Not yet recruiting
      • Oligometastatic Renal Cell Carcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 21, 2023